Company profile
RxElite, Inc.
OTC: RXEI · Healthcare · Drug Manufacturers - Specialty & Generic
#764 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
——FH —DQ —GM —SS 29
v0.1 · 5/100 weight · pillars only
↑ operating margin, revenue growth (YoY) · ↓ Piotroski F, market scale
Methodology →Revenue TTM
$10.4M
Rev growth YoY (TTM)
+660.0%
Net income (FY)
-$17.2M
Employees
47
as of 2026-08-31
Market cap
$1.5k
as of 2026-08-31
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$2.8M$2.8M2007
Net income-$17.2M-$17.2M2007
Operating income$12.3M$12.3M2007
Total assets$21.3M$21.3M2007
Liabilities$9.0M$9.0M2007
Equity$12.3M$12.3M2007
Revenue trend
FY2004 – FY2007 · USD
FY04
FY05
FY06
FY07
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is RxElite, Inc.’s revenue?
RxElite, Inc. booked $2.8M in FY2007 revenue, growing 139% year over year — faster than most Healthcare companies we track, at a -610.5% net margin.
Peers · Healthcare
Dental Patient Care America, Inc.73BUpstream Bio, Inc.44DMedical Supply International USA, Inc.——Absci Corporation47DHypha Labs, Inc.35DQHSLab, Inc.70BNeighbors
Ada →Key facts
CEORichard Tener
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersMeridian, ID
ExchangeOTC: RXEI
Employees47
IPO date2020-02-18
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.